Memantine acts as an N-methyl-D-aspartate (NMDA) receptor antagonist for cognitive support. By blocking excessive glutamate activity, this substance modulates neurological signaling to assist with cognitive function stability during neurodegenerative processes.
Memantine belongs to the class of drugs known as NMDA-receptor antagonists. It is the principal active compound used to modulate abnormal brain signaling that can affect memory and cognition. In Singapore, this substance is incorporated into several oral formulations marketed under the name Memantine.
The active ingredient appears in tablets and, in some cases, orally disintegrating tablets that contain a consistent dose of the compound. Both brand-named and generic options are listed on the Health Sciences Authority’s registry, allowing patients to receive the same therapeutic molecule regardless of the label. Formulations are typically supplied in strengths ranging from 5 mg to 20 mg per tablet.
Memantine is commonly employed to address cognitive decline associated with neuro-degenerative disorders. The primary conditions include:
The compound is generally considered for adults who experience progressive memory loss and who require an additional pharmacological option alongside standard care.
By gently blocking excessive activity at the NMDA (N-methyl-D-aspartate) receptor, the drug helps prevent overstimulation of nerve cells. This moderation reduces calcium influx that can otherwise lead to neuronal stress. The overall effect is a steadier environment for brain cells, which may support clearer thinking and smoother information processing.
The compound may interact with other central nervous system agents, including certain antidepressants and antipsychotics, potentially amplifying side-effects. Alcohol consumption can also intensify dizziness. For a complete list of interacting substances, refer to the individual medication’s detailed information.
Storage should be in a cool, dry place away from direct sunlight and out of reach of children. Tablets are intended for oral use and should be taken with or without food, following the schedule printed on the product label. Treatment duration varies; some users may require short-term use during an acute phase, while others continue for many months to manage chronic symptoms. For precise dosing, strength selection, and administration instructions, consult the specific product’s clinical information.
This article provides an educational overview of memantine as an active substance and does not constitute medical advice. Individual medicines containing this compound-such as the listed memantine tablets-may differ in formulation, strength, and usage directions. The information presented carries no liability for clinical decisions. Readers are encouraged to review the labeling of their specific product and to seek guidance from a healthcare professional when needed.
